Compile Data Set for Download or QSAR

Found 6 hits Enz. Inhib. hit(s) with Target = 'Indoleamine 2,3-dioxygenase 1' and Ligand = 'BDBM223017'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Indoleamine 2,3-dioxygenase 1 (Homo sapiens (Human))	BDBM223017 (US10034939, Example 19 | US10967060, Example 19 | ...) Show SMILES CS(=O)(=O)NCCNc1nonc1C(Nc1ccc(F)c(c1)C#N)=NO |w:24.26| Show InChI InChI=1S/C13H14FN7O4S/c1-26(23,24)17-5-4-16-12-11(20-25-21-12)13(19-22)18-9-2-3-10(14)8(6-9)7-15/h2-3,6,17,22H,4-5H2,1H3,(H,16,21)(H,18,19)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<500	n/a	n/a	n/a	n/a	6.5	25
Incyte Corporation; Incyte Holdings Corporation US Patent					Assay Description Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...				US Patent US9320732 (2016) BindingDB Entry DOI: 10.7270/Q26M35Q9
					More data for this Ligand-Target Pair
Indoleamine 2,3-dioxygenase 1 (Homo sapiens (Human))	BDBM223017 (US10034939, Example 19 | US10967060, Example 19 | ...) Show SMILES CS(=O)(=O)NCCNc1nonc1C(Nc1ccc(F)c(c1)C#N)=NO |w:24.26| Show InChI InChI=1S/C13H14FN7O4S/c1-26(23,24)17-5-4-16-12-11(20-25-21-12)13(19-22)18-9-2-3-10(14)8(6-9)7-15/h2-3,6,17,22H,4-5H2,1H3,(H,16,21)(H,18,19)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<500	n/a	n/a	n/a	n/a	6.5	25
The University of Chicago US Patent					Assay Description Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...				US Patent US10034939 (2018) BindingDB Entry DOI: 10.7270/Q2NK3H2M
					More data for this Ligand-Target Pair
Indoleamine 2,3-dioxygenase 1 (Homo sapiens (Human))	BDBM223017 (US10034939, Example 19 | US10967060, Example 19 | ...) Show SMILES CS(=O)(=O)NCCNc1nonc1C(Nc1ccc(F)c(c1)C#N)=NO |w:24.26| Show InChI InChI=1S/C13H14FN7O4S/c1-26(23,24)17-5-4-16-12-11(20-25-21-12)13(19-22)18-9-2-3-10(14)8(6-9)7-15/h2-3,6,17,22H,4-5H2,1H3,(H,16,21)(H,18,19)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<500	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...				Citation and Details BindingDB Entry DOI: 10.7270/Q2KD222H
					More data for this Ligand-Target Pair
Indoleamine 2,3-dioxygenase 1 (Homo sapiens (Human))	BDBM223017 (US10034939, Example 19 | US10967060, Example 19 | ...) Show SMILES CS(=O)(=O)NCCNc1nonc1C(Nc1ccc(F)c(c1)C#N)=NO |w:24.26| Show InChI InChI=1S/C13H14FN7O4S/c1-26(23,24)17-5-4-16-12-11(20-25-21-12)13(19-22)18-9-2-3-10(14)8(6-9)7-15/h2-3,6,17,22H,4-5H2,1H3,(H,16,21)(H,18,19)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<500	n/a	n/a	n/a	n/a	n/a	n/a
Incyte Holdings Corporation; Incyte Corporation US Patent					Assay Description Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...				US Patent US9789094 (2017) BindingDB Entry DOI: 10.7270/Q27W6F9F
					More data for this Ligand-Target Pair
Indoleamine 2,3-dioxygenase 1 (Homo sapiens (Human))	BDBM223017 (US10034939, Example 19 | US10967060, Example 19 | ...) Show SMILES CS(=O)(=O)NCCNc1nonc1C(Nc1ccc(F)c(c1)C#N)=NO |w:24.26| Show InChI InChI=1S/C13H14FN7O4S/c1-26(23,24)17-5-4-16-12-11(20-25-21-12)13(19-22)18-9-2-3-10(14)8(6-9)7-15/h2-3,6,17,22H,4-5H2,1H3,(H,16,21)(H,18,19)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<500	n/a	n/a	n/a	n/a	n/a	n/a
The University of Chicago US Patent					Assay Description Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...				US Patent US10967060 (2021) BindingDB Entry DOI: 10.7270/Q2XK8JPG
					More data for this Ligand-Target Pair
Indoleamine 2,3-dioxygenase 1 (Homo sapiens (Human))	BDBM223017 (US10034939, Example 19 | US10967060, Example 19 | ...) Show SMILES CS(=O)(=O)NCCNc1nonc1C(Nc1ccc(F)c(c1)C#N)=NO |w:24.26| Show InChI InChI=1S/C13H14FN7O4S/c1-26(23,24)17-5-4-16-12-11(20-25-21-12)13(19-22)18-9-2-3-10(14)8(6-9)7-15/h2-3,6,17,22H,4-5H2,1H3,(H,16,21)(H,18,19)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<500	n/a	n/a	n/a	n/a	6.5	25
Incyte Holdings Corporation; Incyte Corporation US Patent					Assay Description Human indoleamine 2,3-dioxygenasae (IDO) with an N-terminal His tag was expressed in E. coli and purified to homogeneity. IDO catalyzes the oxidative...				US Patent US10034864 (2018) BindingDB Entry DOI: 10.7270/Q2SB47SX
					More data for this Ligand-Target Pair